Search Results

Bromosporine 50 mg  | 99.65%

TargetMol

Bromosporine is a broad spectrum inhibitor for bromodomains for BRD2/4/9 and CECR2 (IC50: 0.41/0.29/0.122/0.017 μM), respectively.

More Information Supplier Page

Bromosporine 10 mg  | 99.65%

TargetMol

Bromosporine is a broad spectrum inhibitor for bromodomains for BRD2/4/9 and CECR2 (IC50: 0.41/0.29/0.122/0.017 μM), respectively.

More Information Supplier Page

Ceftiofur hydrochloride 100 mg  | 99.51%

TargetMol

Ceftiofur Hydrochloride is the hydrochloride salt form of ceftiofur, a semisynthetic, beta-lactamase-stable, broad-spectrum, third-generation cephalosporin with antibacterial activity.

More Information Supplier Page

GSK461364 100 mg  | 99.00%

TargetMol

GSK461364(Ki=2.2 nM) inhibits purified Plk1 .The specificity of GSK461364 for Plk1 is more than 1000-fold over Plk2/3.

More Information Supplier Page

GSK461364 10 mg  | 99.00%

TargetMol

GSK461364(Ki=2.2 nM) inhibits purified Plk1 .The specificity of GSK461364 for Plk1 is more than 1000-fold over Plk2/3.

More Information Supplier Page

GSK461364 2 mg  | 99.00%

TargetMol

GSK461364(Ki=2.2 nM) inhibits purified Plk1 .The specificity of GSK461364 for Plk1 is more than 1000-fold over Plk2/3.

More Information Supplier Page

GSK461364 50 mg  | 99.00%

TargetMol

GSK461364(Ki=2.2 nM) inhibits purified Plk1 .The specificity of GSK461364 for Plk1 is more than 1000-fold over Plk2/3.

More Information Supplier Page

GSK461364 5 mg  | 99.00%

TargetMol

GSK461364(Ki=2.2 nM) inhibits purified Plk1 .The specificity of GSK461364 for Plk1 is more than 1000-fold over Plk2/3.

More Information Supplier Page